Table of Contents

At first glance, Victoza and Saxenda might seem identical. Both are injectable medications formulated from the same active ingredient, liraglutide. They also belong to the same class of drugs, which makes some people assume they’re the same. However, they’re approved for different purposes. Victoza is prescribed for diabetes, while Saxenda is used to manage obesity. If you’re considering these treatment options, this Victoza vs. Saxenda guide that covers key differences, side effects, and costs will help you decide which best suits your health goals.

Key Takeaways

  • Victoza and Saxenda are glucagon-like peptide-1 (GLP-1) receptor agonists made from liraglutide.
  • The FDA has approved Victoza for treating Type 2 diabetes, while Saxenda is approved for managing obesity and overweight.
  • Clinical trials reveal that Saxenda is better for weight loss than Victoza; Victoza’s weight loss benefit is only secondary to its blood sugar-lowering effects.
  • On the other hand, Victoza may be more effective at lowering average blood sugar levels than Saxenda. It’s also suitable and can be taken by Type 2 diabetes patients regardless of their body mass index (BMI).
  • Both Victoza and Saxenda can interact with oral medications because of their effect on slowing digestion. Let your healthcare provider know about your medications to prevent interactions.

Are Victoza and Saxenda the Same?

Saxenda and Victoza Pens

Victoza and Saxenda are identical in the following ways:

    • Class of drugs: Glucagon-like peptide-1 (GLP-1) receptor agonists
    • Active ingredient: Liraglutide
    • Administration: Subcutaneous injection
    • Manufacturer: Novo Nordisk
    • Mechanism of action: Both mimic the hormone GLP-1, which regulates blood sugar, slows gastric emptying, and increases satiety.
    • Common side effects: Nausea, vomiting, and diarrhea
    • Drug interactions: Some oral medications

Victoza and Saxenda are a type of glucagon-like peptide-1 (GLP-1) receptor agonist and work the same way. They contain the same active ingredient, liraglutide, which is delivered through subcutaneous injection.

Once injected, liraglutide functions as synthetic GLP-1, a hormone produced in the pancreas, to increase insulin secretion when blood sugar is high, suppress glucagon that raises blood sugar, and slow digestion to reduce overall calorie intake.

So, is Saxenda the same as Victoza due to these shared features? No. Although Novo Nordisk manufactures both prescription-only drugs, they’re approved for different purposes.

Victoza was approved by the FDA in 2010 for treating Type 2 diabetes in children and adults, whereas Saxenda was approved in 2010 for managing obesity and overweight in children and adults. They’re not interchangeable and shouldn’t be used simultaneously.

Both Saxenda and Victoza slow digestion, which can delay the absorption of some oral medications. Inform your doctor about any other medications you’re taking to prevent potential interactions.

What Is the Difference Between Victoza and Saxenda?

Saxenda and Victoza have notable distinctions, so you can’t substitute one for the other. Here’s a table summarizing their differences.

Victoza Saxenda
FDA approved for Treat Type 2 diabetes Manage weight in people who are overweight and obese
Indicated for Adults and children aged 10 and older with Type 2 diabetes Adult patients with a body mass index (BMI) of:
  • 30 kg/m2 or greater (obese), or
  • 27 kg/m2 or greater (overweight) with at least one weight-related comorbid condition
Children 12 years and older with:
  • Body weight above 60 kg, and
  • A BMI that corresponds to obese by adult standards
Dosage
  • Week 1: initial dose of 0.6 mg daily
  • Week 2: 1.2 mg daily
  • Week 3: maximum dose of 1.8 mg daily
  • Week 1: initial dose of 0.6 mg daily
  • Week 2: 1.2 mg daily
  • Week 3: 1.8 mg daily
  • Week 4: 2.4 mg daily
  • Week 5: recommended dose of 3 mg daily
Dosage form and strength 6 mg/mL solution in a prefilled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg 6 mg/mL solution in a 3 mL prefilled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, or 3 mg
Price from Drugs.com $1,450.10 $590.21

1. FDA Approval

The FDA has approved both Victoza and Saxenda, but for different uses.

Victoza treats Type 2 diabetes in adults and children aged 10 and older and is prescribed to lower the risk of heart complications in patients with co-existing diabetes and heart conditions.

Meanwhile, Saxenda is FDA-approved to treat obesity and overweight in adults with a BMI of 30 kg/m2 or higher and 27 kg/m2 or higher with one weight-related comorbidity, like hypertension, dyslipidemia, and Type 2 diabetes.

It’s also recommended for children aged 12 and older who weigh over 60 kg and have a BMI that corresponds to adult obesity.

2. Victoza vs. Saxenda Dosage

The starting dose for both Victoza and Saxenda is 0.6 mg and titrated until the maximum or recommended dosage is reached. The highest dose of Victoza is 1.8 mg, while the recommended daily dosage of Saxenda is 3 mg.

Healthcare providers may adjust the dose in pediatric patients based on how well they tolerate the side effects and other health-related factors.

How often is Victoza administered? Victoza and Saxenda are injected once daily in the thigh, abdomen, or upper arm at any time, with or without meals.

3. Side Effects

Victoza and Saxenda cause almost the same side effects. However, since Saxenda is titrated to a much higher dose, users often experience more and stronger gastrointestinal adverse reactions, especially during increased doses. These symptoms typically subside over time.

Common side effects of Victoza include:

    • Nausea
    • Diarrhea
    • Dyspepsia
    • Constipation
    • Vomiting
    • Decreased appetite
    • Immunogenicity-related events, including urticaria

Typical adverse reactions of Saxenda include:

    • Nausea
    • Diarrhea
    • Injection site reactions
    • Fatigue
    • Dizziness
    • Abdominal pain
    • Constipation
    • Vomiting
    • Increased lipase
    • Upper abdominal pain
    • Pyrexia
    • Gastroenteritis
    • Headache
    • Hypoglycemia
    • Dyspepsia

Rare but serious risks for both drugs include:

    • Pancreatitis
    • Thyroid C-cell tumors
    • Acute gallbladder disease
    • Damage to the kidneys
    • Low blood sugar levels
    • Hypersensitivity reactions
    • Pulmonary aspiration

Saxenda users are also at a rare risk of developing depression, which may lead to suicidal thoughts or behaviors. Speak with your doctor if you experience unusual symptoms, so they can adjust the dose or treatment plan accordingly.

4. Effectiveness: Victoza vs. Saxenda for Weight Loss

Although approved for diabetes, Victoza has some weight loss benefits. How does it compare with Saxenda?

In a clinical trial, researchers divided 746 adults with Type 2 diabetes into three groups. One group took glimepiride — an anti-diabetic medication — and the rest were randomized to receive 1.2 mg and 1.8 mg of Victoza.

After 52 weeks, the results were as follows:

    • Those who took 1.2 mg of Victoza lost 2.1 kg  (4.6 lbs) from the baseline body weight of 92.1 kg
    • Patients treated with 1.8 mg of Victoza lost 2.5 kg (5.5 lbs) from the baseline weight of 92.6 kg.
    • Those who took glimepiride gained 1.1 kg (2.4 lbs) from the baseline weight of 93.3 kg.

These results show Victoza users lost between 2.3% and 2.7% of their body weight.

In a separate study, people who were obese or overweight with one weight-related comorbidity were treated with Saxenda, titrated to 3 mg daily over 4 weeks. Treatment included a calorie-restricted diet and at least 150 minutes of physical activity every week. Participants had a baseline weight of 107.5 kg.

After 56 weeks, the findings were:

    • 62.3% of patients lost at least 5% of their body weight
    • 33.9% lost at least 10% of their weight

If you want to reduce your BMI, Saxenda is a better option than Victoza. You may lose some pounds with Victoza, but this benefit is secondary to its glucose-lowering effects.

5. Saxenda vs. Victoza for Diabetes 

Victoza may be more effective at lowering blood sugar levels than Saxenda.

In the same clinical trial, those treated with Victoza 1.2 mg and 1.8 mg for 52 weeks reduced their HbA1c by 0.8% and 1.1%, respectively, from the baseline average of 8.2%.

Meanwhile, patients with obesity and co-occurring diabetes who took 3 mg of Saxenda titrated in 4 weeks decreased their HbA1c by 1.3% from 7.9% after 56 weeks of treatment.

Both drugs show significant changes in HbA1c levels.

6. Saxenda vs. Victoza Price

An 18 mg/3 mL solution of Saxenda costs $1,450.10, while an 18 mg/3 mL of Victoza is priced at $590.21.

Insurance coverage, patient assistance, and manufacturer savings programs can help reduce medication costs if you qualify.

Another way to afford Victoza or Saxenda is to purchase them in online Canadian pharmacies. Online prescription delivery platforms like Buy Canadian Insulin offer up to 90% off your injections.

You can get five prefilled pens of 6mg/mL of Saxenda for $515 instead of $1,450 and two prefilled pens of 6 mg/mL of Victoza for only $255 instead of $590.21. If it’s your first time ordering, you get an additional 10% off your prescriptions using the coupon code FIRST10.

Even without insurance, it’s easier to afford your medications by buying from us. We provide express shipping from Canada to ensure your injections arrive safely and on time.

Alternatives to Victoza and Saxenda

Alternatives to Victoza and Saxenda 

Generic liraglutide is a good alternative to Saxenda and Victoza. The FDA recently approved it for treating Type 2 diabetes alongside diet and exercise.

Here are other GLP-1 agonists that your doctor may prescribe in exchange for liraglutide:

    • Ozempic (semaglutide): Treat Type 2 diabetes
    • Trulicity (dulaglutide): Also approved for Type 2 diabetes
    • Mounjaro (tirzepatide): A dual GLP-1 and gastric inhibitory polypeptide (GIP) agonist approved for Type 2 diabetes
    • Wegovy (semaglutide): Approved for treating obesity and overweight

If your doctor suggests switching to another medication for a medically valid reason, these Saxenda and Victoza alternatives are some of the best ones to consider.

Victoza vs. Saxenda: Which Is Better For Diabetes and Weight Loss

Victoza and Saxenda are both GLP-1 drugs that contain liraglutide. They have the exact mechanism of action, mimicking GLP-1 to suppress appetite and normalize blood sugar levels.

Victoza is approved for Type 2 diabetes, whereas Saxenda treats obesity and overweight. Both have been shown to effectively reduce HbA1c levels and body weight in clinical trials.

Because Saxenda and Victoza are once-daily injections, they can be costly for Americans who don’t have insurance or do not qualify for savings programs. Purchasing prescriptions from Canadian prescription delivery platforms like Buy Canadian Insulin lowers out-of-pocket medication expenses. Generic liraglutide is also available for those looking for a cheaper option.

If you want to switch medications, ask your doctor for personalized advice before changing your prescriptions.

Frequently Asked Questions

Victoza is cleared for treating Type 2 diabetes, not weight loss. Its maximum dose of 1.8 mg is lower than Saxenda’s 3 mg recommended daily dose, which limits its weight loss potential.
Other GLP-1 agonists that may be more effective than Victoza for weight loss are Saxenda, Mounjaro, and Wegovy. Wegovy and Saxenda are both approved for weight management. Mounjaro, a dual GIP and GLP-1 receptor agonist, also promotes significant weight loss but is currently approved for diabetes treatment.
Based on a study, taking once-weekly semaglutide, combined with diet and exercise, leads to more weight loss than once-daily liraglutide. Wegovy and Ozempic contain semaglutide and may work better if your goal is to slim down.
There’s no optimal dosing timing for Victoza. Doctors recommend taking the injection daily at any time, with or without a meal. It’s recommended to establish a consistent dosing schedule to avoid missed injections.
Victoza is injected under the skin in the abdomen, thigh, or upper arm once daily, either in the morning, afternoon, or evening, with or without food.
Saxenda results in more weight reduction because it’s titrated to a much higher dose than Victoza. The highest dose for Saxenda is 3 mg, while Victoza is capped at 1.8 mg for its maximum dose.
Although both are GLP-1 agonists and contain liraglutide, Saxenda and Victoza aren’t interchangeable. One reason is that they vary in doses. Moreover, Saxenda is used to manage obesity and overweight, while Victoza is prescribed for diabetes.
Victoza is a brand-name injection pen that contains liraglutide. Generic liraglutide and Victoza are approved by the FDA to treat Type 2 diabetes.

Original Publish Date: 3/01/2021 – Updated 5/16/2025